Results 11 to 20 of about 5,540 (198)

Chemical Ligand Space of Cereblon [PDF]

open access: yesACS Omega, 2018
The protein cereblon serves as a substrate receptor of a ubiquitin ligase complex that can be tuned toward different target proteins by cereblon-binding agents. This approach to targeted protein degradation is exploited in different clinical settings and
Iuliia Boichenko   +7 more
doaj   +8 more sources

Cereblon ligands

open access: yes, 2022
The disclosure provides compds. of formula I,​and the salts and solvates thereof. The disclosure also relates to uses of the compds. as cereblon (CRBN) ubiquitination inhibitors, as synthetic intermediates that can be used to prep.
Wang, shaomeng, Rej, Rohan
core   +3 more sources

Cereblon: A Protein Crucial to the Multiple Functions of Immunomodulatory Drugs as well as Cell Metabolism and Disease Generation [PDF]

open access: yesJournal of Immunology Research, 2017
It is well known that cereblon is a key protein in autosomal recessive nonsyndromic mental retardation. Studies have reported that it has an intermediary role in helping immunomodulatory drugs perform their immunomodulatory and tumoricidal effects.
Qinglin Shi, Lijuan Chen
doaj   +2 more sources

UBE2G1 governs the destruction of cereblon neomorphic substrates

open access: yeseLife, 2018
The cereblon modulating agents (CMs) including lenalidomide, pomalidomide and CC-220 repurpose the Cul4-RBX1-DDB1-CRBN (CRL4CRBN) E3 ubiquitin ligase complex to induce the degradation of specific neomorphic substrates via polyubiquitination in ...
Gang Lu   +17 more
doaj   +3 more sources

Tubulin Resists Degradation by Cereblon-Recruiting PROTACs [PDF]

open access: yesCells, 2020
Dysregulation of microtubules and tubulin homeostasis has been linked to developmental disorders, neurodegenerative diseases, and cancer. In general, both microtubule-stabilizing and destabilizing agents have been powerful tools for studies of ...
Ivana Gasic   +7 more
doaj   +3 more sources

Generalizable Strategies for the Synthesis of Cereblon-Recruiting PROTAC Prodrugs. [PDF]

open access: yesAngew Chem Int Ed Engl
Cereblon‐recruiting PROTACs remain challenging to derivatize for prodrug‐based delivery. In this study, three complementary conjugation strategies enabled the efficient synthesis of cleavable PROTAC prodrugs with tunable release kinetics that can be incorporated into a library of PEGylated constructs and bottlebrush prodrugs.
Wang AX   +7 more
europepmc   +3 more sources

Molecular glues: Recent advances in cereblon substrate identification and mechanistic insights. [PDF]

open access: yesSmart Mol
Molecular glues exert diverse core biological functions by inducing or stabilizing protein–protein interactions, extending far beyond the traditional scope of targeted protein degradation. Key breakthroughs include expanded cereblon substrate recognition, sustained G protein‐coupled receptor megacomplex signaling, and the first orthosteric molecular ...
Guan Q   +5 more
europepmc   +2 more sources

E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points

open access: yesFrontiers in Chemistry, 2021
Proteolysis-targeting chimeras (PROTACs) have received tremendous attention as a new and exciting class of therapeutic agents that promise to significantly impact drug discovery.
Aleša Bricelj   +4 more
doaj   +1 more source

Tumor and microenvironmental mechanisms of resistance to immunomodulatory drugs in multiple myeloma

open access: yesFrontiers in Oncology, 2022
Resistance to immunomodulatory drugs (IMiDs®) is a major cause of treatment failure, disease relapse and ultimately poorer outcomes in multiple myeloma (MM). In order to optimally deploy IMiDs and their newer derivates CRBN E3 ligase modulators (CELMoDs®)
Lucia Y. Chen   +4 more
doaj   +1 more source

Cereblon-recruiting proteolysis targeting chimeras (PROTACs) can determine the selective degradation of HDAC1 over HDAC3

open access: yes
Histone deacetylase (HDAC) enzymes 1–3 exist in several corepressor complexes and are viable drug targets. To date, proteolysis targeting chimeras (PROTACs) designed to target HDAC1–3 typically exhibit the selective degradation of HDAC3.
Urvashi Patel (20139240)   +7 more
core   +5 more sources

Home - About - Disclaimer - Privacy